Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cooper Companies

This article was originally published in The Gray Sheet

Executive Summary

Federal judge fines the company more than $3 mil. on July 15 for seven counts of mail and wire fraud. The company says it must pay $1.8 mil. over three years and a restitution payment of $1.3 mil. due within 30 days. Cooper and former co-chairman Gary Singer were convicted of insider trading-related criminal charges in January ("The Gray Sheet" Jan. 17, p. 16); Cooper says that Singer's sentencing will occur "at a later date." Cooper also has "negotiated a settlement" of a November 1992 civil suit filed by the Securities and Exchange Commission against the firm, Singer; and several other parties for insider trading and manipulation of a Cooper debenture's trading price to avoid an interest rate reset. The company has agreed to "permanent injunctions against violation of certain provisions of the federal securities laws and against employment of any members of the Singer family." The SEC agreement also includes a $1.6 mil. disgorgement and a $1.2 mil. civil penalty, which is "reduced by the amounts of the restitution and fine" in the federal court's sentencing, leaving a $311,308 disgorgement payment

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002622

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel